• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Quantitative structure-activity relationships (QSARs) in inhibitors of various cytochromes P450: the importance of compound lipophilicity.

作者信息

Lewis David F V, Lake Brian G, Dickins Maurice

机构信息

School of Biomedical and Molecular Sciences, University of Surrey, Guildford, Surrey GU2 7XH, UK.

出版信息

J Enzyme Inhib Med Chem. 2007 Feb;22(1):1-6. doi: 10.1080/14756360600952183.

DOI:10.1080/14756360600952183
PMID:17373540
Abstract

The results of extensive quantitative structure-activity relationship (QSAR) analyses on 15 series of cytochrome P450 inhibitors, covering a total of 7 enzymes and 199 compounds, are reported. In general, it is found that lipophilicity represents the most important single factor in describing differences in inhibitory potency towards P450 enzymes. In two instances, this relationship is parabolic in nature but, by and large, the logarithm of inhibitory activity relates linearly with log P, where P is the octanol-water partition coefficient. On occasions, other parameters are involved in the QSAR expressions but there are many examples where either log P or its ionization-corrected equivalent, log D7.4, are the sole structural descriptors of inhibition. The correlations presented exhibit a range in R value from 0.85 to 0.99, where R is the correlation coefficient, and it is found that R is greater than 0.9 in 80% of the QSARs presented. It is apparent from these findings, therefore, that compound lipophilicity plays a major role in the ability of xenobiotics to inhibit enzymes of the cytochrome P450 superfamily, presumably due to the essentially hydrophobic nature of the active site region.

摘要

相似文献

1
Quantitative structure-activity relationships (QSARs) in inhibitors of various cytochromes P450: the importance of compound lipophilicity.
J Enzyme Inhib Med Chem. 2007 Feb;22(1):1-6. doi: 10.1080/14756360600952183.
2
Quantitative structure-activity relationships (QSARs) for inhibitors and substrates of CYP2B enzymes: importance of compound lipophilicity in explanation of potency differences.CYP2B 酶抑制剂和底物的定量构效关系(QSARs):化合物脂溶性在解释效价差异中的重要性。
J Enzyme Inhib Med Chem. 2010 Oct;25(5):679-84. doi: 10.3109/14756360903514149.
3
Quantitative structure-activity relationships (QSars) in CYP3A4 inhibitors: the importance of lipophilic character and hydrogen bonding.细胞色素P450 3A4抑制剂的定量构效关系:亲脂性特征和氢键的重要性。
J Enzyme Inhib Med Chem. 2006 Apr;21(2):127-32. doi: 10.1080/14756360500532747.
4
Quantitative structure-activity relationships (QSARs) within cytochromes P450 2B (CYP2B) subfamily enzymes: the importance of lipophilicity for binding and metabolism.
Drug Metabol Drug Interact. 2006;21(3-4):213-31. doi: 10.1515/dmdi.2006.21.3-4.213.
5
Quantitative structure-activity relationships (QSARs) within series of inhibitors for mammalian cytochromes P450 (CYPs).哺乳动物细胞色素P450(CYPs)抑制剂系列中的定量构效关系(QSARs)。
J Enzyme Inhib. 2001 Oct;16(4):321-30.
6
Lipophilicity relationships in inhibitors of CYP2C9 and CYP2C19 enzymes.细胞色素P450 2C9和2C19酶抑制剂的亲脂性相关性
J Enzyme Inhib Med Chem. 2006 Aug;21(4):385-9. doi: 10.1080/14756360600703313.
7
Quantitative structure-activity relationships (QSARs) for substrates of human cytochromes P450 CYP2 family enzymes.
Toxicol In Vitro. 2004 Feb;18(1):89-97. doi: 10.1016/s0887-2333(03)00134-6.
8
Human cytochromes P450 associated with the phase 1 metabolism of drugs and other xenobiotics: a compilation of substrates and inhibitors of the CYP1, CYP2 and CYP3 families.与药物及其他外源性物质的Ⅰ相代谢相关的人类细胞色素P450:CYP1、CYP2和CYP3家族底物及抑制剂汇编
Curr Med Chem. 2003 Oct;10(19):1955-72. doi: 10.2174/0929867033456855.
9
Structure-activity relationship for human cytochrome P450 substrates and inhibitors.人类细胞色素P450底物和抑制剂的构效关系
Drug Metab Rev. 2002 Feb-May;34(1-2):69-82. doi: 10.1081/dmr-120001391.
10
Insights on cytochrome p450 enzymes and inhibitors obtained through QSAR studies.通过定量构效关系研究获得的细胞色素 p450 酶和抑制剂的见解。
Molecules. 2012 Aug 3;17(8):9283-305. doi: 10.3390/molecules17089283.

引用本文的文献

1
Orally Bioavailable Proteolysis-Targeting Chimeras: An Innovative Approach in the Golden Era of Discovering Small-Molecule Cancer Drugs.口服生物可利用的蛋白酶靶向嵌合体:小分子抗癌药物发现黄金时代的一种创新方法。
Pharmaceuticals (Basel). 2024 Apr 12;17(4):494. doi: 10.3390/ph17040494.
2
Descriptors of Cytochrome Inhibitors and Useful Machine Learning Based Methods for the Design of Safer Drugs.细胞色素抑制剂的描述以及基于机器学习的更安全药物设计实用方法
Pharmaceuticals (Basel). 2021 May 17;14(5):472. doi: 10.3390/ph14050472.
3
Coumarins and P450s, Studies Reported to-Date.
香豆素与 P450 酶,迄今为止的研究报告。
Molecules. 2019 Apr 24;24(8):1620. doi: 10.3390/molecules24081620.
4
Review of Ligand Specificity Factors for CYP1A Subfamily Enzymes from Molecular Modeling Studies Reported to-Date.基于迄今报告的分子模拟研究对CYP1A亚家族酶的配体特异性因素的综述。
Molecules. 2017 Jul 8;22(7):1143. doi: 10.3390/molecules22071143.
5
Use of In Vitro and Predictive In Silico Models to Study the Inhibition of Cytochrome P4503A by Stilbenes.使用体外和预测性计算机模拟模型研究芪类化合物对细胞色素P4503A的抑制作用。
PLoS One. 2015 Oct 20;10(10):e0141061. doi: 10.1371/journal.pone.0141061. eCollection 2015.
6
Interactions between CYP3A4 and Dietary Polyphenols.细胞色素P450 3A4与膳食多酚之间的相互作用。
Oxid Med Cell Longev. 2015;2015:854015. doi: 10.1155/2015/854015. Epub 2015 Jun 9.
7
Insights on cytochrome p450 enzymes and inhibitors obtained through QSAR studies.通过定量构效关系研究获得的细胞色素 p450 酶和抑制剂的见解。
Molecules. 2012 Aug 3;17(8):9283-305. doi: 10.3390/molecules17089283.